|
Mechanism5-HT2C receptor antagonists [+2] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date19 Feb 2009 |
100 Clinical Results associated with Xinwen Biomedical Technology (Jiashan) Co., Ltd.
0 Patents (Medical) associated with Xinwen Biomedical Technology (Jiashan) Co., Ltd.
100 Deals associated with Xinwen Biomedical Technology (Jiashan) Co., Ltd.
100 Translational Medicine associated with Xinwen Biomedical Technology (Jiashan) Co., Ltd.